Metabolic Availability of Lysine From Wheat in Adult Men


Protein is the key determinant of growth and bodily functions. The quality of food proteins depend on their amino acid content and the amount of amino acids used by the body to make proteins. Globally Cereal Grains (CG) provide 50% of the calories and protein in the diet and exceed 80% in poorer developing countries. In many of those countries, wheat is the major cereal grain in the diet. The protein in wheat is low in the essential amino acid lysine. Hence wheat protein is of low quality. Low lysine affects protein synthesis in the body. Cooking methods also affect the lysine available from foods to the body.The protein can be complemented by the addition of lentils to augment the low lysine content. However, lentils are prohibitively expensive in some developing countries. As the human population increases, the world faces the continuous challenge of maximizing a limited food supply. Protein quality (PQ) evaluation of wheat directly in humans would allow us to bridge the gap in knowledge between what is required and how best to provide.The information gathered from this project will provide the first direct experimental data on PQ of wheat protein in humans on which nutrition recommendations can be built.

Full Title of Study: “Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From Indian Wheat, in Healthy Young Adult Men”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 1, 2019

Detailed Description

Each subject will be part of 8 different experimental diets, and randomly assigned to one of the diets every time. 4 reference diet would be based on egg protein composition, 3 wheat diets would have protein from baked wheat bread and 1 mixed meal would comprise of baked wheat bread and lentils. Each experimental diet will be studied over 3 days: 2 adaptation and 1 study day. The 2 adaptation meals would be consumed at home. On the study day 3, following a 12-h overnight fast, subjects will come to the research unit at The Hospital for Sick Children, Toronto, ON for a period of 7.5 h and consume the diet as 9 hourly meals. The first 3 meals would be consumed at home. For the duration of all experiments, subjects will consume a daily multivitamin supplement to ensure adequate vitamin intake. Measurements: 1. Resting energy expenditure (REE) will be measured by open-circuit indirect calorimetry 2. Body composition (fat and fat free mass) will be measured by BIA and Skin Fold. 3. Breath samples will be collected after the 4th and 7th meals.


  • Dietary Supplement: Metabolic availability of lysine in wheat
    • Four levels of lysine intakes will be provided by the reference protein drinks, 3 levels of lysine from wheat and 1 level from wheat with lentils.

Arms, Groups and Cohorts

  • Experimental: metabolic availability of lysine in wheat
    • Participants will be seen initially for pre-study assessment (2 hour). They will then be studied at 8 levels of lysine intake. Subjects will visit SickKid’s Clinical Research Center a total of 9 times, with each visit being at least one week before the next. All 9 visits must be made within 6 months. Each set of experiment consists of a 3 day period. During the first 2 days (Adaptation Days) you will be expected to consume 4 meals per day consisting of a protein liquid drink and protein free-cookies and/or a baked wheat bread with or without lentils, which will all be provided by the investigators.

Clinical Trial Outcome Measures

Primary Measures

  • Metabolic availability of Lysine in Indian Wheat
    • Time Frame: 2 years
    • Apply the IAAO method to determine the Metabolic availability of Lysine in Indian Wheat prepared by dry heat cooking method.

Participating in This Clinical Trial

Inclusion Criteria

  • Male, age 18 – 49 yrs – Healthy, with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes – Stable Body Weight – Not on any medications that could affect protein or amino acid metabolism e.g. steroids Exclusion Criteria:

  • Unwillingness to participate or unable to tolerate the diet – Recent history of weight loss within the last 3 months or on a weight reducing diet – Inability to tolerate study diets (ex. Allergy to ingredients)

Gender Eligibility: Male

Minimum Age: 18 Years

Maximum Age: 49 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • The Hospital for Sick Children
  • Collaborator
    • Canadian Institutes of Health Research (CIHR)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Glenda Courtney-Martin, Dietician – The Hospital for Sick Children
  • Overall Official(s)
    • Glenda Courtney-Martin, BSc, MSc, PhD, Principal Investigator, The Hospital for Sick Children

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.